March 23, 2023 | AI, POLARIS Quantum Biotech, Shahar Keinan, artificial intelligence, drug discovery, health technology, machine learning, precision medicine, quantum biotech, quantum computing
Dr. Shahar Keinan, Co-founder & CEO of POLARIS Quantum Biotech, explores quantum computing and AI for drug discovery, the Quantum Molecular Design process, and how POLARISqb is working to improve precision medicine and find cures for all known diseases.
To find out more about Impetus: https://www.meetwithimpetus.com
Impetus Digital Website: https://www.impetusdigital.com/
Impetus Digital Twitter: https://twitter.com/impetus_digital
Impetus Digital Podcast: https://impetusdigital.buzzsprout.com
Impetus Digital LinkedIn: https://www.linkedin.com/company/impe…
Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieye…
Dr. Shahar Keinan: https://www.linkedin.com/in/shahar-ke…
Polaris Quantum Biotech: https://polarisqb.com/
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Samuel Searcy, Founder & CEO of CliniStart, shares his expert insights into trends, current gaps, and future predictions for clinical trials. Among many other things, we also dive into his...
Dr. Harsh Vathsangam, CEO & Co-Founder of Moving Analytics, shares his expertise on mobile health and discusses how it can be used to improve patient adherence and access to cardiac...
Tom Hsu, VP of Specialty Medicine at Bayer Canada, talks about how he got to where he is today and his experience working for Bayer in China and how that...
Eddie Power, Vice President of North America Medical Affairs, Hospital Business at Pfizer, discusses a range of topics, including the effects of COVID-19 on the way Medical Affairs teams work...
Craig Lipset, Founder and Advisor at Clinical Innovation Partners and former Head of Clinical Innovation and Venture Partner at Pfizer, talks about everything from his personal health journey to his...
Esther Schorr, Co-founder and Chief Operating Officer of Patient Power LLC, discusses non-linear journey to patient education and Patient Power's mission to empower patients and their loved ones to take...
Jim Lefevere, Director of Global Marketing Services at Roche, discusses the changes in digital marketing strategies, workflow, team dynamics, and required skill sets among Pharma teams brought on by COVID-19....
Max Newlon, President of Brain Co., discusses everything from meditation practices and behavioral science to the use of technology in assessing and treating mental health conditions. He also delves into...
Andreas Weber, Group CEO, EvidentIQ, discusses hybrid vs. fully decentralized trials, the use of real-world evidence (RWE) in clinical trials, and how an end-to-end eClinical solution can help meet increasing...
Read the full article here or on the Green Business Bureau blog for more details.